Specialty Drug Spending Continues to Rise, Driven by Higher Utilization

Per-member per-year (PMPY) specialty drug spending rose 13.6% from 2018 to 2019, according to Pharmaceutical Strategies Group’s annual report, which analyzed 45 million pharmacy claims and 54 million medical claims. Contributing to the growth was a 10.3% increase in utilization and a 3.3% rise in costs per claim. Specialty drug spending under the pharmacy benefit saw the largest increase, driven by 19.6% higher utilization of such therapies. In terms of overall cost, inflammatory disorders ranked No. 1 among all drug categories, followed by oncology and multiple sclerosis.

SOURCE: “State of Specialty Spend and Trend Report,” Pharmaceutical Strategies Group, October 2020. Visit https://bwnews.pr/2HUxyiJ.

Jinghong Chen

Jinghong Chen Reporter

Jinghong produces infographics and data stories on health insurance and specialty pharmacy for AIS Health. She graduated from Missouri School of Journalism with a focus on data journalism and international reporting. Before joining AIS in 2018, she worked at WBEZ, Al Jazeera English and The New York Times Chinese.

Related Posts

icons
February 15

All Eyes Are on Novel New Therapies, Impact of IRA, AI

Read More
bladder-cancer
February 15

FDA Approves Game-Changing Regimen for Urothelial Cancer, but Will Cost Pose Issue?

Read More
gavel-on-a-book
February 15

Copay Accumulator Lawsuit Comes to an End; Will Ruling Be Enforced?

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today